Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? (Q37845609)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2011

Language	Label	Description	Also known as
English	Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?	scientific article published on January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

Europe PubMed Central

Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

connective tissue

1 reference

based on heuristic

inferred from title

interstitial lung disease

1 reference

based on heuristic

inferred from title

Elisabetta Renzoni

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Angelo de Lauretis

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Srihari Veeraraghavan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 January 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Chronic Respiratory Disease

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

53-82

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21339375%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rheumatoid arthritis-related lung diseases: CT findings.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rapidly progressive fatal interstitial lung disease in a patient with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in primary Sjögren syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary function tests in connective tissue disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Racial differences in scleroderma among women in Michigan

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical manifestations of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Severe restrictive lung disease in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Risk factors for the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Death rates and causes of death in patients with rheumatoid arthritis: a population-based study.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in recent onset rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Cigarette smoking and rheumatoid arthritis severity

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Methotrexate-related pulmonary complications in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Methotrexate-Induced Pulmonary Injury: Serial CT findings

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Diffuse alveolar hemorrhage after leflunomide therapy in a patient with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Relationship of gold and penicillamine therapy to diffuse interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sulphasalazine and lung toxicity

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Drug-induced alveolitis caused by salazosulfapyridine

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary complications of tumor necrosis factor-targeted therapy

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Tolerability and safety of rituximab (MabThera).

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The respiratory system in connective tissue disorders

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary complications of polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary disease in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Polymyositis-dermatomyositis-associated interstitial lung disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Computed tomographic imaging in connective tissue diseases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Antisynthetase syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Acute respiratory failure due to diaphragmatic weakness revealing a polymyositis.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Recent advances in the treatment of interstitial lung disease in patients with polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Management of fibrosing alveolitis with polymyositis dermatomyositis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rituximab treatment of the anti-synthetase syndrome: a retrospective case series

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sjogren's syndrome is associated with and not secondary to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The overlap of Sjögren's syndrome with other systemic autoimmune diseases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary lesions associated with Sjögren's syndrome: radiographic and CT findings.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Primary Sjögren's syndrome in north east England--a longitudinal study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary manifestations of Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Increased Risk of Lymphoma in Sicca Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Clinical and imaging findings of lymphoma in patients with Sjögren syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Mortality in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

The epidemiology of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Respiratory manifestations of systemic lupus erythematosus: old and new concepts

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Dyspnoea in a young woman with active systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Interstitial lung disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

A long-term study of interstitial lung disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary alveolar hemorrhage in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Alveolar hemorrhage in systemic lupus erythematosus: presentation and management

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Intravenous immunoglobulin therapy of lupus pneumonitis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Catastrophic antiphospholipid syndrome: where do we stand?

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

High-dose acetylcysteine in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Pirfenidone in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

High-resolution CT imaging of the lung for patients with primary Sjögren’s syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1479972310393758

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37845609&oldid=1516247239"